Dr. Reddy's Laboratories Ltd. (RDY)
13.75
0.00 (0.00%)
USD |
NYSE |
Oct 27, 16:00
13.75
0.00 (0.00%)
After-Hours: 20:00
Dr. Reddy's Laboratories EPS Diluted (Quarterly) : 0.1161 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.1161 |
| June 30, 2026 | 0.0562 |
| March 31, 2026 | 0.0289 |
| December 31, 2025 | 0.1627 |
| September 30, 2025 | 0.1973 |
| June 30, 2025 | 0.1985 |
| March 31, 2025 | 0.2205 |
| December 31, 2024 | 0.2006 |
| September 30, 2024 | 0.1796 |
| June 30, 2024 | 0.2001 |
| March 31, 2024 | 0.1887 |
| December 31, 2023 | 0.1986 |
| September 30, 2023 | 0.2148 |
| June 30, 2023 | 0.2049 |
| March 31, 2023 | 0.1401 |
| December 31, 2022 | 0.1823 |
| September 30, 2022 | 0.1676 |
| June 30, 2022 | 0.185 |
| March 31, 2022 | 0.014 |
| December 31, 2021 | 0.1134 |
| September 30, 2021 | 0.161 |
| June 30, 2021 | 0.0931 |
| March 31, 2021 | 0.0598 |
| December 31, 2020 | 0.0032 |
| September 30, 2020 | 0.1232 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0919 |
| March 31, 2020 | 0.127 |
| December 31, 2019 | -0.0965 |
| September 30, 2019 | 0.187 |
| June 30, 2019 | 0.1147 |
| March 31, 2019 | 0.0742 |
| December 31, 2018 | 0.081 |
| September 30, 2018 | 0.0864 |
| June 30, 2018 | 0.0819 |
| March 31, 2018 | 0.0565 |
| December 31, 2017 | 0.0626 |
| September 30, 2017 | 0.0532 |
| June 30, 2017 | 0.011 |
| March 31, 2017 | 0.0562 |
| December 31, 2016 | 0.0837 |
| September 30, 2016 | 0.0531 |
| June 30, 2016 | 0.0222 |
| March 31, 2016 | 0.0129 |
| December 31, 2015 | 0.1027 |
| September 30, 2015 | 0.129 |
| June 30, 2015 | 0.1153 |
| March 31, 2015 | 0.0975 |
| December 31, 2014 | 0.1085 |
| September 30, 2014 | 0.1102 |
| June 30, 2014 | 0.1078 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Teva Pharmaceutical Industries Ltd. | -0.5029 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 95.57M |
| Revenue (Quarterly) | 907.22M |
| Total Expenses (Quarterly) | 810.43M |
| Enterprise Value | 11.45B |
| Gross Profit Margin (Quarterly) | 48.82% |
| Profit Margin (Quarterly) | 10.53% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 2.78% |
| Normalized Earnings Yield | 2.695 |